| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/05/2001 | WO2000061622A3 Genes associated with diseases of the kidney |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof |
| 07/05/2001 | WO2000050050A8 Multiparticulate formulation |
| 07/05/2001 | WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | WO2000011137A8 Acid labile cationic amphiphiles |
| 07/05/2001 | US20010007152 Obtained by immunizing transgenic mice which produce human leukocyte antigen (HLA) with tumor-associated antigens and recovering the nucleic acids encoding the T cell receptors from the cytotoxic T lymphocytes; diagnosis and therapy |
| 07/05/2001 | US20010007025 Antisense modulation of bcl-x expression |
| 07/05/2001 | US20010006955 Method for recombinant adeno-associated virus-directed gene therapy |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006951 Method of intranasal gene transfer for protection against respiratory infection |
| 07/05/2001 | US20010006948 So the gene is expressed; producing animal models for degenerative disc disease; genetically modified intervertebral disc cells; gene therapy |
| 07/05/2001 | US20010006947 Methods of administering adenoviral vectors |
| 07/05/2001 | US20010006946 Improved gene transfer efficiency by coadministering with a cholic acid or deoxycholic acid amide derivative of given formula |
| 07/05/2001 | US20010006939 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 07/05/2001 | US20010006817 Cell delivery compositions |
| 07/05/2001 | US20010006816 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006815 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006814 Chemical modification |
| 07/05/2001 | US20010006799 Histidine kinase polypeptides |
| 07/05/2001 | US20010006798 Novel FtsL |
| 07/05/2001 | US20010006681 Chemokine inhibition of immunodeficiency virus |
| 07/05/2001 | US20010006642 Delivering antigens or biologically active polypeptides to a subject in need of same by administering to the subject a non-invasive or non-pathogenic bacterium which expresses the antigens or polypeptides |
| 07/05/2001 | US20010006630 Biological material such as cell, and purified extracellular matrix degrading enzyme externally adhered thereto; for treating mucopolysaccharidoses, cystic fibrosis, parkinson's disease, Gaucher's syndrome and osteogeneis imperfecta |
| 07/05/2001 | DE19960924A1 Amphiphile Polyamine, deren Anwendungen und Verfahren zu ihrer Synthese Amphiphilic polyamines, their applications and methods for their synthesis |
| 07/05/2001 | CA2397710A1 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395926A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 07/05/2001 | CA2395839A1 Gene therapy for congestive heart failure |
| 07/05/2001 | CA2395779A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 07/05/2001 | CA2395575A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | CA2395544A1 Method of achieving persistent transgene expression |
| 07/05/2001 | CA2395535A1 Method for the production of vitamin a |
| 07/05/2001 | CA2395454A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | CA2395335A1 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | CA2395320A1 Therapeutic uses of lna-modified oligonucleotides |
| 07/05/2001 | CA2395276A1 Identification of novel splice variants of the human catalytic subunit c.beta. of camp-dependent protein kinase and the use thereof |
| 07/05/2001 | CA2395273A1 A novel isoform of human camp-dependent protein kinase, c.alpha.-s, localizes to sperm midpiece and the use thereof |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395143A1 Novel cdnas encoding catenin-binding proteins with function in signalling and/or gene regulation |
| 07/05/2001 | CA2395003A1 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | CA2394880A1 Activation and inhibition of the immune system |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/05/2001 | CA2394174A1 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | CA2392703A1 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | CA2363180A1 Use of lithium (li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/04/2001 | EP1113020A2 Nucleosides and oligonucleotides containing boron clusters |
| 07/04/2001 | EP1112497A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 07/04/2001 | EP1112372A1 Alternatively targeted adenovirus |
| 07/04/2001 | EP1112371A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/04/2001 | EP1112369A2 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES |
| 07/04/2001 | EP1112368A1 Use of protein kinase kiaa0551 as pharmaceutical |
| 07/04/2001 | EP1112366A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112362A2 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 07/04/2001 | EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 07/04/2001 | EP1112358A2 Dna sequence encoding oncofetal ferritin protein |
| 07/04/2001 | EP1112356A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancers |
| 07/04/2001 | EP1112286A1 Secreted proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112283A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 07/04/2001 | EP1112088A1 Method for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
| 07/04/2001 | EP1112086A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells |
| 07/04/2001 | EP1112083A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 07/04/2001 | EP1112078A2 New use |
| 07/04/2001 | CN1302334A Retroviral delivery system |
| 07/04/2001 | CN1301866A Full gene cloning of horse infectious anemia virus representating virus strain and its use |
| 07/04/2001 | CN1301859A New polypeptide-human space I enzyme 13 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301854A New polypeptide-glycosylhydoxlase 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301768A New polypeptide-human natriuretic peptide receptor 18 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301767A New polypeptide-human RS3 protein 13 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301757A New polypeptide-human protease inhibiting factor 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301732A New polypeptide-thiolase protein 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301717A New polypeptide-gitter protein light chain 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1068009C Isolated nucleic acid molecules as members of the mage-XP family and uses thereof |
| 07/03/2001 | US6255474 Nucleotide sequences coding immunosuppressant for use in organ grafting |
| 07/03/2001 | US6255472 Isolated nucleic acid molecule encoding a human skeletal muscle-specific receptor |
| 07/03/2001 | US6255471 CRFG-1b, a target and marker for chronic renal failure |
| 07/03/2001 | US6255289 Gene delivery by secretory gland expression |
| 07/03/2001 | US6255113 Targeting an exogenous polynucleotide or complementary polynucleotide pair to an endogenous dna target in eukaryotic cells by homologous recombination; genetic disease therapy; sickle cell anemia, thalassemias and genetic cancers |
| 07/03/2001 | US6255112 Co-culturing mesenchymal stem cells with hematopoietic stem cells to produce osteoclasts; the transduced cells express gene products that can be used to modulate bone resorption; therapy of osteoporosis |
| 07/03/2001 | US6255110 Antisense modulation of ARA70 expression |
| 07/03/2001 | US6255105 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/03/2001 | US6255104 A recombinant vector containing an rna polymerase promoter linked to a mutant polio virus nucleic acid sequence, where the coat protein is deleted; gene therapy, antitumor agents, treating autoimmune diseases and human immunodefiecency virus |
| 07/03/2001 | US6255096 An isolated nucleic acid encoding an amino acid; diagnosis and therapy for progressive mental retardation in conjuction with skeletal deformities |
| 07/03/2001 | US6255077 Human DNA topoisomerase I α |
| 07/03/2001 | US6255075 Nucleotide sequences coding biotin holoenzyme synthetase; for the prevention and treatment of bacterial infection |
| 07/03/2001 | US6255073 Cell segment from drosophila; for the treatment of cancer, tumors, viral or retroviral infection and autoimmune diseases |
| 07/03/2001 | US6255072 Nucleotide sequences coding proteolytic polypeptide; for use as diagnostic tool; for the prevention of bacterial infection |
| 07/03/2001 | US6255046 Drug screening of enzyme inhibitors by expressing enzyme or kinase domain, purifying, isolating, adding test compound and fructose 6-phosphate, and measuring formation of fructose 2,6 bisphosphate product; reduction indicates candidate |
| 07/03/2001 | US6254872 Protective immune response against infections |
| 07/03/2001 | US6254870 Amino acid sequences |
| 07/03/2001 | US6254869 Genetic engineering, vaccines and immunoglobulins |
| 07/03/2001 | US6254865 Method of treating huntington's disease using HNT neurons |
| 07/03/2001 | US6254862 Replication-competent adenovirus vectors |
| 07/03/2001 | CA2078773C Gp75 as a tumor vaccine for melanoma |
| 07/03/2001 | CA2047363C Recombinant therapies for infection and hyperproliferative disorders |